Your session is about to expire
← Back to Search
ERC Arm for Gallstones
Study Summary
This trial found that using the SpyGlass™ system to directly view and remove biliary stones was as effective as the standard method of using a fluoroscope to guide a catheter through the biliary ducts.
- Gallstones
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- The stones are located in certain parts of the liver or bile ducts.You have a condition called Primary Sclerosing Cholangitis (PSC).You currently have a severe infection in your bile duct, which is causing symptoms like high fever, fast heart rate, low blood pressure, or pus at the ampulla (opening of the bile duct).You have severe and ongoing abdominal pain that may be caused by gallstones blocking the bile ducts. If necessary, you can have a procedure to remove the gallstones within 72 hours of the start of your symptoms.You have had certain types of surgeries that change the way your stomach and small intestine are connected, except for a specific type of reconstruction called Billroth I. This can make the study procedures more difficult.If the doctor thinks you might have gallstones based on certain criteria, you will need to get additional tests like MRCP or EUS imaging to confirm the presence of stones.You have had a procedure called biliary sphincterotomy in the past.
- Group 1: ERC Arm
- Group 2: DSC Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there vacancies available for aspiring participants of this clinical experiment?
"The information on clinicaltrials.gov indicates that this medical investigation is still open for recruitment; it was publicly announced in September 2018, and the details were last refreshed on November 28th 2022."
How many physical sites are currently offering this research?
"Presently, this clinical trial is taking place at 4 sites: Houston, Stanford and Aurora being some of the notable locations. To help ease travel burdens for participants it is recommended to pick a centre close by when enrolling."
How many individuals are actively participating in this clinical experiment?
"This medical trial requires 297 participants, who meet the designated eligibility criteria. There are many potential sites for enrolment such as Ertan Digestive Disease Center - University of Texas Health Science Center in Houston and Stanford University Medical Center in Stanford."
Share this study with friends
Copy Link
Messenger